An update from Lantheus ( (LNTH) ) is now available.
Lantheus Holdings, Inc., a leader in radiopharmaceuticals, has announced the appointment of Julie Eastland, a seasoned biotech and financial executive, to its Board of Directors. Eastland, recognized for her expertise in finance, strategic planning, and operations, joins the Board as an independent director and will serve on the Audit Committee. Her appointment reflects Lantheus’ commitment to growth and innovation, with the Board now consisting of ten members, eight of whom are independent, bolstering the company’s governance as it continues to enhance patient care.
See more insights into LNTH stock on TipRanks’ Stock Analysis page.
